Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease.

@article{Beaton2013PhaseIC,
  title={Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease.},
  author={Melanie D. Beaton and Subrata Chakrabarti and Mark A Levstik and Mark Speechley and Paul J. Marotta and Paul Adams},
  journal={Alimentary pharmacology & therapeutics},
  year={2013},
  volume={37 7},
  pages={720-9}
}
BACKGROUND Elevated iron indices are described in non-alcoholic fatty liver disease and iron reduction has been suggested as a potential therapy. AIM To determine whether phlebotomy is an effective therapy for non-alcoholic fatty liver disease. METHODS Patients with biopsy proven non-alcoholic fatty liver disease underwent baseline evaluation to determine severity of metabolic and liver disease. A Phase II trial of phlebotomy was carried out to achieve near-iron depletion (serum ferritin… CONTINUE READING
31 Citations
46 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 31 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 46 references

Similar Papers

Loading similar papers…